Trials / Completed
CompletedNCT02897856
Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures
Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Hamad Medical Corporation · Industry
- Sex
- All
- Age
- 6 Months – 14 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to prove that intramuscular midazolam is more effective than buccal midazolam in cessation of seizure activity with comparable side effects.
Detailed description
Both buccal and intramuscular midazolam have been used to control seizures with variable succuss rates and side effects. In this study the investigators are going to assign patient randomly to receive either buccal or intramuscular midazolam. Then will compare both efficacy and side effect in both groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buccal midazolam | Study subject will receive Buccal midazolam, Intramuscular placebo. |
| DRUG | Intramuscular midazolam | Study subject will receive Intramuscular midazolam,Buccal placebo |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2018-11-01
- Completion
- 2018-11-01
- First posted
- 2016-09-13
- Last updated
- 2019-07-24
Locations
1 site across 1 country: Qatar
Source: ClinicalTrials.gov record NCT02897856. Inclusion in this directory is not an endorsement.